Benitec Biopharma Inc. (BNTC) Capital expenditures 2019–2026
Benitec Biopharma Inc. (BNTC) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$105,000FY2026 · since FY2019: $404,000 → $105,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $105,000 | +483.3% |
| FY2025 | $18,000 | -89.9% |
| FY2024 | $179,000 | +17800.0% |
| FY2023 | $1,000 | -92.3% |
| FY2022 | $13,000 | -94.1% |
| FY2021 | $221,000 | +132.6% |
| FY2020 | $95,000 | -76.5% |
| FY2019 | $404,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice